Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.050
+0.020 (1.94%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Vivani Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Selling, General & Admin
8.93105.372.322.38
Upgrade
Research & Development
15.7516.9714.17116.87
Upgrade
Operating Expenses
24.6826.9719.5413.329.24
Upgrade
Operating Income
-24.68-26.97-19.54-13.32-9.24
Upgrade
Other Non Operating Income (Expenses)
1.191.310.480.55-0.04
Upgrade
EBT Excluding Unusual Items
-23.49-25.65-19.07-12.77-9.28
Upgrade
Legal Settlements
---1.7--
Upgrade
Other Unusual Items
--6.88--
Upgrade
Pretax Income
-23.49-25.65-13.89-12.77-9.28
Upgrade
Earnings From Continuing Operations
-23.49-25.65-13.89-12.77-9.28
Upgrade
Net Income
-23.49-25.65-13.89-12.77-9.28
Upgrade
Net Income to Common
-23.49-25.65-13.89-12.77-9.28
Upgrade
Shares Outstanding (Basic)
5551383310
Upgrade
Shares Outstanding (Diluted)
5551383310
Upgrade
Shares Change (YoY)
8.12%32.98%15.56%234.38%-
Upgrade
EPS (Basic)
-0.43-0.50-0.36-0.39-0.94
Upgrade
EPS (Diluted)
-0.43-0.50-0.36-0.39-0.94
Upgrade
Free Cash Flow
-21.34-24.59-19.13-11.52-7.77
Upgrade
Free Cash Flow Per Share
-0.39-0.48-0.50-0.35-0.79
Upgrade
EBITDA
-24.28-26.61-19.16-12.98-8.89
Upgrade
D&A For EBITDA
0.40.360.380.350.35
Upgrade
EBIT
-24.68-26.97-19.54-13.32-9.24
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q